urapidil has been researched along with Diabetes Mellitus, Type 2 in 2 studies
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oren, S | 1 |
| Turkot, S | 1 |
| Paran, E | 1 |
| Flandra, O | 1 |
| Slezak, L | 1 |
| Hof, B | 1 |
| Fariello, R | 1 |
| Boni, E | 1 |
| Corda, L | 1 |
| Zaninelli, A | 1 |
| Noseda, A | 1 |
| Spinazzi, A | 1 |
2 trials available for urapidil and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Efficacy and tolerability of slow release urapidil (ebrantil) in hypertensive patients with non-insulin dependent diabetes mellitus (NIDDM).
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure Determination; Diabetes Mellitus, Type 2; | 1996 |
Influence of a new multifactorial antihypertensive on blood pressure and metabolic profile in essential hypertension associated with non-insulin-dependent diabetes mellitus.
Topics: Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Benzothiadiazines; Blood Pressure; Diab | 1992 |